ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Global Virus Network Warns Measles Resurgence

TAMPA, Fla., Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, collaboration, and pandemic preparedness, expresses deep concern regarding the ongoing resurgence of measles in the United States and around the globe. Measles is one of the most contagious viral diseases known and can be lethal, particularly in unvaccinated children. Yet, it remains entirely preventable with a highly effective vaccine, with an outstanding safety record established since the 1960s.

In 2025, the United States experienced its highest number of measles cases in more than 30 years, with more than 2,242 confirmed cases across 45 states and at least 11% of patients requiring hospitalization, including cases among young children, and three confirmed deaths, a dramatic increase compared to recent years. Collective data indicate that measles outbreaks continue into early 2026, with states such as South Carolina reporting hundreds of active cases in localized outbreaks. Public health officials warn that the U.S., like Canada, may soon lose its long-held measles elimination status if transmission persists.

The U.S. Centers for Disease Control and Prevention (CDC) shows that the 2025 total represents a significant resurgence compared to prior years, and many outbreaks have been linked to low vaccination coverage and international travel.

“Measles anywhere is a threat everywhere,” said Professor Scott Weaver, MS, PhD, a GVN Center of Excellence Director at The University of Texas Medical Branch, “These outbreaks are the result of long-standing global challenges in maintaining high childhood vaccination coverage and persistent vulnerabilities in public health systems.”

Across the globe, measles activity remains elevated. According to the World Health Organization (WHO), even though a safe and cost-effective vaccine is available, in 2024, there were an estimated 95,000 measles deaths globally, mostly among unvaccinated or under-vaccinated children under the age of 5 years.

“Strengthening routine immunization, surveillance, and public education is essential to prevent further outbreaks,” said Professor Heidi Larson, PhD, founding director of The Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine and GVN Board of Directors Member. “The MMR vaccine is proven, safe, and effective, and maintaining high coverage is our best defense.”

GVN urges governments, healthcare providers, and public health agencies to:

  • Promote and facilitate MMR immunization of all unvaccinated children and adults.
  • Strengthen measles surveillance systems to rapidly detect and respond to outbreaks before they spread.
  • Combat vaccine misinformation through evidence-based public communication.
  • Support global immunization efforts to reduce preventable disease and deaths worldwide.

Media Contact:

Nora Samaranayake

nsamaranayake@gvn.org

About the Global Virus Network
The Global Virus Network (GVN) is a worldwide coalition comprising 90+ Virology Centers of Excellence and Affiliates across 40+ countries, whose mission is to facilitate pandemic preparedness against viral pathogens and diseases that threaten public health globally. GVN advances knowledge of viruses through (i) data-driven research and solutions, (ii) fostering the next generation of virology leaders, and (iii) enhancing global resources for readiness and response to emerging viral threats. GVN provides the essential expertise required to discover and diagnose viruses that threaten public health, understand how such viruses spread illnesses, and facilitate the development of diagnostics, therapies, and treatments to combat them. GVN coordinates and collaborates with local, national, and international scientific institutions and government agencies to provide real-time virus informatics, surveillance, and response resources and strategies. GVN's pandemic preparedness mission is achieved by focusing on Education & Training, Qualitative & Quantitative Research, and Global Health Strategies & Solutions. The GVN is a non-profit 501(c)(3) organization. For more information, please visit www.gvn.org.


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  239.30
+0.00 (0.00%)
AAPL  259.48
+0.00 (0.00%)
AMD  236.73
+0.00 (0.00%)
BAC  53.20
+0.00 (0.00%)
GOOG  338.53
+0.00 (0.00%)
META  716.50
+0.00 (0.00%)
MSFT  430.29
+0.00 (0.00%)
NVDA  191.13
+0.00 (0.00%)
ORCL  164.58
+0.00 (0.00%)
TSLA  430.41
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.